£0.21
£0.00 (0.00%)
End-of-day quote: 05/17/2024
AIM:AGL
ANGLE Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $595.30 | $591.94 | 0.00% | 1 | $227.24B |
| ROG | Roche Holding | SWX | Hold | CHF237.10 | CHF307.83 | 0.00% | 9 | CHF191.28B |
| ILMN | Illumina | NasdaqGS | Outperform | $111.07 | $159.28 | 0.00% | 9 | $17.69B |
| NTRA | Natera | NasdaqGS | Buy | $106.46 | $74.41 | 0.00% | 8 | $11.68B |
| 6869 | Sysmex | TSE | Outperform | ¥7.99k | ¥8.90k | 0.00% | 0 | ¥1.74T |
| QGEN | QIAGEN N.V. | NYSE | Outperform | $45.69 | $0.00 | 0.00% | 3 | $9.67B |
| GH | Guardant Health | NasdaqGS | Buy | $25.36 | $43.00 | 0.00% | 2 | $2.37B |
| NEO | NeoGenomics | NasdaqCM | Outperform | $14.80 | $20.09 | 0.00% | 9 | $1.95B |
| ATOS | Atossa Genetics Inc | NASDAQ | Buy | $1.57 | $4.83 | 0.00% | 0 | $187.38M |
| 8YY | Biolidics | Catalist | - | $0.01 | $0.00 | 0.00% | 0 | $53.09M |
| NVTA | Invitae | NYSE | - | $0.00 | $0.71 | 0.00% | 8 | $3.18M |
| BIOC.Q | Biocept | OTCPK | Hold | $0.00 | $8.00 | 0.00% | 0 | $0.13M |
